Form 4 for AMD Advanced Micro Devices
Accepted 2021-09-02 00:00:00 ET · period of report 2021-08-31 · accession 0000002488-21-000160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-02 | 2021-08-31 | AMD | KUMAR DEVINDER | EVP, CFO, Treas | M - OptEx | $6.98 | +74.0K | 598.4K | +14% | +$516.7K |
| DM | 2021-09-02 | 2021-08-31 | AMD | KUMAR DEVINDER | EVP, CFO, Treas | S - Sale+OE | $110.43 | -74.0K | 524.4K | -12% | -$8.17M |
| D | 2021-09-02 | 2021-08-31 | AMD | KUMAR DEVINDER | EVP, CFO, Treas | M - OptEx | $0.00 | -74.0K | 148.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-31 | M | A | 74,020 | $6.98 | 598,390 | D | — | — | (F1) The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. |
| 2 | Common | Common Stock | 2021-08-31 | S | D | 71,729 | $110.41 | 526,661 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F3) Transaction executed in multiple trades at prices ranging from $109.97 to $110.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-08-31 | S | D | 2,291 | $111.15 | 524,370 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F4) Transaction executed in multiple trades at prices ranging from $110.97 to $111.19 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option Grant | 2021-08-31 | M | D | 74,020 | $0.00 | 148,041 | D | $6.98 · — to — | 74,020 Common Stock | (F5) This option vests 33 1/3% on July 26, 2017 and 8 1/3% per quarter over the subsequent eight quarters. |